Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: Case report and review of the literature

References

• Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563–71
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestermann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–15
   PubMed Web of Science ®Google Scholar
• Perfect JR, Marr KA, Walsh TJ, Greenberg RN, Du Pont B, de la Torre-Cisneros J, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003; 36: 1122–31
   PubMed Web of Science ®Google Scholar
• Wingard JR. Empirical antifungal therapy in treating febrile neutropenic patients. Clin Infect Dis 2004; 39(Suppl 1)S38–43
   PubMed Web of Science ®Google Scholar
• Klastersky J. Empirical antifungal therapy. Int J Antimicrob Agents 2004; 23: 105–12
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225–34
   PubMed Web of Science ®Google Scholar
• Garbino J, Rohner P, Kolarova L, Ondrusova A, Lew D. Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy. Infection 2003; 31: 241–3
   PubMed Web of Science ®Google Scholar
• Chow L, Brown NE, Kunimoto D. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis. Clin Infect Dis 2002; 35: 106–10
   PubMed Web of Science ®Google Scholar
• van't Hek LG, Verweij PE, Weemaes CM, van Dalen R, Yntema JB, Meis JF. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease. Am J Respir Crit Care Med 1998; 157: 1694–6
   PubMed Web of Science ®Google Scholar
• Rosen-Wolff A, Koch A, Friedrich W, Hahn G, Gahr M, Roesler J. Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease. Pediatr Infect Dis J 2004; 23: 584–6
   PubMedGoogle Scholar
• Tattevin P, Bruneel F, Lellouche F, de Broucker T, Chevret S, Wolff M, et al. Successful treatment of brain aspergillosis with voriconazole. Clin Microbiol Infect 2004; 10: 928–31
   PubMed Web of Science ®Google Scholar
• Lassaletta A, Perez A, Diaz MA, Gonzalez-Vicent M, Madero L. Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukaemia. J Pediatr Hematol Oncol 2004; 26: 117–9
   PubMed Web of Science ®Google Scholar
• Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of haematopoietic stem-cell transplants. N Engl J Med 2004; 350: 950–2
   PubMed Web of Science ®Google Scholar
• Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt A, Kilborn SB, Hoth PL, et al. Invasive zygomycosis in haematopoietic stem-cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584–7
   PubMed Web of Science ®Google Scholar
• Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem-cell transplant recipients receiving voriconazole. Clin Infect Dis 2004; 39: 743–6
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Kami M, Murashige N, Kishi Y, Fujisaki G, Mitamura T. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis. Haematologica 2004; 89: ECR42
   PubMedGoogle Scholar
• Steinbach WJ, Benjamin DK, Jr, Kontoyiannis DP, Perfect JR, Lutsar I, Marr KA, et al. Infections due to Aspergillus terreus: a multicentre retrospective analysis of 83 cases. Clin Infect Dis 2004; 39: 192–8
   PubMed Web of Science ®Google Scholar
• Reichenberger F, Habicht J, Kaim A, Dalquen P, Bernet F, Schlapfer R, et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with haematological diseases. Am J Respir Crit Care Med 1998; 158: 885–90
   PubMed Web of Science ®Google Scholar